- Home
- HNNA vs NVNO Comparison
HNNA vs NVNO Comparison
Compare HNNA & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNNA
- NVNO
- Stock Information
- Founded
- HNNA 1989
- NVNO 1987
- Country
- HNNA United States
- NVNO United States
- Employees
- HNNA N/A
- NVNO N/A
- Industry
- HNNA Investment Managers
- NVNO Medical/Dental Instruments
- Sector
- HNNA Finance
- NVNO Health Care
- Exchange
- HNNA Nasdaq
- NVNO Nasdaq
- Market Cap
- HNNA 73.8M
- NVNO 59.4M
- IPO Year
- HNNA N/A
- NVNO N/A
- Fundamental
- Price
- HNNA $10.50
- NVNO $3.28
- Analyst Decision
- HNNA
- NVNO
- Analyst Count
- HNNA 0
- NVNO 0
- Target Price
- HNNA N/A
- NVNO N/A
- AVG Volume (30 Days)
- HNNA 7.1K
- NVNO 96.4K
- Earning Date
- HNNA 12-04-2024
- NVNO 10-31-2024
- Dividend Yield
- HNNA 5.26%
- NVNO N/A
- EPS Growth
- HNNA 25.53
- NVNO N/A
- EPS
- HNNA 0.80
- NVNO N/A
- Revenue
- HNNA $27,126,000.00
- NVNO N/A
- Revenue This Year
- HNNA N/A
- NVNO N/A
- Revenue Next Year
- HNNA N/A
- NVNO N/A
- P/E Ratio
- HNNA $13.15
- NVNO N/A
- Revenue Growth
- HNNA 11.90
- NVNO N/A
- 52 Week Low
- HNNA $6.36
- NVNO $3.01
- 52 Week High
- HNNA $11.99
- NVNO $6.97
- Technical
- Relative Strength Index (RSI)
- HNNA 60.03
- NVNO 39.99
- Support Level
- HNNA $10.13
- NVNO $3.25
- Resistance Level
- HNNA $10.65
- NVNO $3.68
- Average True Range (ATR)
- HNNA 0.33
- NVNO 0.15
- MACD
- HNNA 0.02
- NVNO 0.03
- Stochastic Oscillator
- HNNA 61.28
- NVNO 9.20
About HNNA Hennessy Advisors Inc.
Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced and fixed income products. It provides investment advisory services and shareholder services to the Hennessy Funds. Its investment advisory services include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities in accordance with the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).